| ID | 117185 |
| Author |
Okada, Masaki
Sakamoto Hospital
Bando, Hiroshi
Sakamoto Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association
KAKEN Search Researchers
Iwatsuki, Noboru
Sakamoto Hospital
Sakamoto, Kazuki
Sakamoto Hospital
Ogawa, Tomoya
Sakamoto Hospital
|
| Keywords | Imeglimin
Twymeeg
Duloxetine Hydrochloride
Cymbalta
Type 2 Diabetes
Depression
Mild Cognitive Impairment
|
| Content Type |
Journal Article
|
| Description | Background: Imeglimin (Twymeeg) has been effective for patients with type 2 diabetes (T2D).
Case Presentation: The patient is an 82-year-old female with T2D, arthralgia, and depression. Results: She was given duloxetine hydrochloride (Cymbalta) and Twymeeg, leading to improved symptoms of low back pain (LBP), knee osteoarthritis, osteoporosis, depression, and possible mild cognitive impairment (MCI). HbA1c decreased from 8.8% to 7.1% for 4 months with a single administration of Twymeeg 2000mg/day. Discussion: In recent clinical practice, elderly cases often tend to have simultaneously these problems, which are medical and social crucial problems. Twymeeg and Cymbalta may be indispensable agents for future practice. |
| Journal Title |
Diabetes Research : Open Access
|
| Publisher | Asploro
|
| Volume | 4
|
| Issue | 1
|
| Start Page | 1
|
| End Page | 7
|
| Published Date | 2022-06-06
|
| Rights | This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
| DOI (Published Version) | |
| URL ( Publisher's Version ) | |
| FullText File | |
| language |
eng
|
| TextVersion |
Publisher
|
| departments |
Medical Sciences
|
